BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

605 related articles for article (PubMed ID: 6151892)

  • 1. Alpha- and beta-blockade in angina pectoris.
    Taylor SH
    Drugs; 1984; 28 Suppl 2():69-87. PubMed ID: 6151892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of nitrates, nitrate-like substances, calcium antagonists and beta-adrenergic receptor blockers on peripheral circulation].
    Busse R; Bassenge E
    Herz; 1982 Dec; 7(6):388-405. PubMed ID: 6131027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic and coronary hemodynamic effects of combined alpha- and beta-adrenergic blockade (labetalol) in normotensive patients with stable angina pectoris and positive exercise stress test responses.
    Prida XE; Hill JA; Feldman RL
    Am J Cardiol; 1987 May; 59(12):1084-8. PubMed ID: 2883869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Labetalol therapy in patients with systemic hypertension and angina pectoris: effects of combined alpha and beta adrenoceptor blockade.
    Frishman WH; Strom JA; Kirschner M; Poland M; Klein N; Halprin S; LeJemtel TH; Kram M; Sonnenblick EH
    Am J Cardiol; 1981 Nov; 48(5):917-28. PubMed ID: 6118060
    [No Abstract]   [Full Text] [Related]  

  • 5. Properties of labetalol, a combined alpha- and beta-blocking agent, relevant to the treatment of myocardial ischemia.
    Frishman WH
    Cardiovasc Drugs Ther; 1988 Sep; 2(3):343-53. PubMed ID: 2908732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined alpha- and beta-receptor inhibition in the treatment of hypertension.
    Prichard BN
    Drugs; 1984; 28 Suppl 2():51-68. PubMed ID: 6151891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined receptor intervention and myocardial infarction.
    Chamberlain DA; Vincent R
    Drugs; 1984; 28 Suppl 2():88-108. PubMed ID: 6151893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta blockade and the effects of stress on the normal and ischaemic heart.
    Prichard BN
    Aviat Space Environ Med; 1981 Nov; 52(11 Pt 2):S9-18. PubMed ID: 6118124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical pharmacology of beta-adrenoceptor antagonism in angina pectoris: an overview.
    Oh VM
    Ann Acad Med Singap; 1980 Oct; 9(4):498-507. PubMed ID: 6113811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antianginal actions of beta-adrenoceptor antagonists.
    O'Rourke ST
    Am J Pharm Educ; 2007 Oct; 71(5):95. PubMed ID: 17998992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Labetalol in the treatment of angina pectoris.
    Kanto JH
    Int J Clin Pharmacol Ther Toxicol; 1987 Mar; 25(3):166-74. PubMed ID: 2881899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beneficial effect of labetalol in hypertensive patients with angina pectoris.
    Lubbe WF; White DA
    S Afr Med J; 1983 Jan; 63(3):67-71. PubMed ID: 6849167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Open evaluation of labetalol in the treatment of angina pectoris occurring in hypertensive patients.
    Besterman EM; Spencer M
    Br J Clin Pharmacol; 1979; 8(Suppl 2):205S-209S. PubMed ID: 526402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Labetalol in hypertensive patients with angina pectoris: beneficial effect of combined alpha- and beta-adrenoreceptor blockade.
    Lubbe WF; White DA
    Clin Sci Mol Med Suppl; 1978 Dec; 4():283s-286s. PubMed ID: 32006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The possible role of the ancillary properties of beta adrenoceptor antagonists in the management of angina pectoris.
    Fitzgerald JD
    Acta Med Scand Suppl; 1985; 694():120-41. PubMed ID: 2860771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacology of combined alpha-beta-blockade. I.
    Louis WJ; McNeil JJ; Drummer OH
    Drugs; 1984; 28 Suppl 2():16-34. PubMed ID: 6151889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of action of beta-blocking drugs in angina pectoris: a review.
    Robinson BF
    Postgrad Med J; 1976; 52 Suppl 4():43-5. PubMed ID: 9630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential hemodynamic effects of beta-adrenoceptor blockers, Ca antagonists and combined alpha-beta-receptor blockade in ischemic heart disease.
    Koch G
    Acta Med Scand; 1986; 219(1):17-22. PubMed ID: 2869648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect on left ventricular performance of nifedipine and metoprolol singly and together in exercise-induced angina pectoris.
    Nelson GI; Silke B; Ahuja RC; Hussain M; Forsyth D; Taylor SH
    Eur Heart J; 1984 Jan; 5(1):67-79. PubMed ID: 6705807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological and clinical aspects of drug therapy in coronary heart disease: clinical aspects of therapy with beta-adrenoceptor antagonists.
    Prichard BN
    Z Kardiol; 1990; 79 Suppl 3():99-103. PubMed ID: 1983055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.